Acrolein (2-propenal) is a highly reactive α,β-unsaturated
aldehyde and a respiratory
irritant that is ubiquitously present in the environment but that can also be generated endogenously at sites of
inflammation.
Acrolein is abundant in tobacco
smoke, which is the major environmental risk factor for
chronic obstructive pulmonary disease (
COPD), and elevated levels of
acrolein are found in the lung fluids of
COPD patients. Its high electrophilicity makes
acrolein notorious for its facile reaction with
biological nucleophiles, leading to the modification of
proteins and
DNA and depletion of
antioxidant defenses. As a consequence,
acrolein results in oxidative stress as well as altered intracellular signaling and gene transcription/translation. In pulmonary cells,
acrolein, at subtoxic concentrations, can activate intracellular stress
kinases, alter the production of inflammatory mediators and
proteases, modify innate immune response, induce mucus hypersecretion, and damage airway epithelium. A better comprehension of the mechanisms underlying
acrolein effects in the airways may suggest novel treatment strategies in
COPD.